Is Botanix Pharmaceuticals Limited (BXPHF) a Buy, Sell, or Hold?
OTC : BXPHF
Botanix Pharmaceuticals Limited
$0.015 USD
$0 (0.0%)
- Volume
- 25K
- Average Volume
- 15.42K
- Market Capitalization
- $41.01M
- P/E Ratio
- -0.49
- Dividend Yield
- 0.00%
- Price Target
- $0.27
- Year High
- $0.13
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.56
Company Overview
OTC
Howie McKibbon
Medical - Pharmaceuticals
Healthcare
BXPHF
11
AU
USD
Liquidity Metrics
0.57
2.56
1.56
1.14
0.00
Sales & Valuation
$5.76M
2.09
0.84
-0.57
-0.04
Profitability
-$0.0468
-$86.4M
-404.72%
-404.72%
-131.13%
-89.99%
P/E Metrics
-0.49
0.00
0.00
Analyst Price Target & Rating
$0.27
$0.27
$0.27
2/5
0 Analysts
-94.44%
Financial Health Scores
-5.83
3/9
$43.06M
$98.53M
$44.56M
-$124.99M
Key Metrics (TTM)
$44.88M
2.05
-0.55
2.56
-131.13%
-99.26%
-196.35%
-176.45%
252 days
Company Executives
| Name | Title |
|---|---|
| Boris Meyerson | Chief Business Officer |
| Howie McKibbon | Chief Executive Officer |
| Chris Lesovitz | Chief Financial Officer of United States of America |
| Darin Van Arsdale | Director of Sales Operations |
| Andrew Bickley | Joint Company Secretary |
| Paul Seaback | Chief Operating Officer |
| Vincent Ippolito | MD & Executive Chairman |
| Kevin Wojciechowski | Head of HCP Marketing & Sales Training |
| David Morgan | Head of Corporate Affairs |
| Graeme Morissey | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Botanix Pharmaceuticals Limited (OTC:BXPHF) Stock
Botanix Pharmaceuticals Ltd is a dermatology company that focuses on developing safe and effective topical treatments for serious skin conditions. The company's product pipeline includes treatments for conditions such as moderate to severe acne, atopic dermatitis, rosacea, and axillary hyperhidrosis. It has an exclusive license to use a proprietary drug delivery system for skin diseases. ...
2026-07-26 23:30:24
Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Commercial Progress of Sofdra for Primary Axillary Hyperhidrosis Transcript
Frequently Asked Questions
-
What is the current Botanix Pharmaceuticals Limited (BXPHF) stock price?
-
Botanix Pharmaceuticals Limited(OTC:BXPHF) stock price is $0.015 in the last trading session. During the trading session, BXPHF stock reached the peak price of $0.1341 while $0.01 was the lowest point it dropped to. The percentage change in BXPHF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BXPHF stock was $0.
-
BXPHF's industry and sector of operation?
-
The OTC listed BXPHF is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of BXPHF?
-
Boris Meyerson | Chief Business Officer
Howie McKibbon | Chief Executive Officer
Chris Lesovitz | Chief Financial Officer of United States of America
Darin Van Arsdale | Director of Sales Operations
Andrew Bickley | Joint Company Secretary -
How many employees does BXPHF have?
-
Number of BXPHF employees currently stands at 11. BXPHF operates from 41-47 Colin Street, West Perth, WA 6005, AU.
-
Link for BXPHF official website?
-
Official Website of BXPHF is: https://www.botanixpharma.com
-
How do I contact BXPHF?
-
BXPHF could be contacted at phone #61 8 6555 2945 and can also be accessed through its website. BXPHF operates from 41-47 Colin Street, West Perth, WA 6005, AU.
-
How many shares of BXPHF are traded daily?
-
The average number of BXPHF shares traded daily for last 3 months was 15.42K.
-
What is the market cap of BXPHF currently?
-
The market value of BXPHF currently stands at $41.01M with its latest stock price at $0.015